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Robotripping: The Dangers of Abusing Dextromethorphan
Tiffany Sin1 DO, James Espinosa2 DO, Dana Fichter RN3
1Emergency Medicine Residency and Department of Emergency Medicine, Rowan University, SOM
3Emergency Department, Jefferson Health New Jersey, Stratford Campus
Introduction
Dextromethorphan (3-methoxy-N-methylmorphinan),
also known as “DXM,” is a synthetically produced
drug available in many over-the- counter (OTC)
cough and cold medications as a centrally acting
cough suppressant that binds to NMDA receptors. In
a 2006 national survey of 50,000 students, 4, 5, and
7% of 8, 10, and 12th graders reported DXM abuse
in the past yearn [1]. In high doses, DXM can cause
euphoria, hallucinations, dissociations, and distortion
of cognition and perception [3]. DXM abuse is also
known as “Robotripping,” “Robodosing,” “Dexing,”
“Tussin,” or “Triple Cs” because Robitussin and
Coricidin Cough and Cold are most frequently
abused. DXM has replaced codeine and
promethazine in many cough syrup preparations, yet
it is still known as “Purple drank,” “Lean,” “Sizzurp,”
“Orange Crush,” or “Skittles” when mixed with
alcohol or soda for flavor. Co-toxicity can occur since
DXM is usually combined with acetaminophen,
antihistamines, or decongestants like
pseudoephedrine. DXM reaches its peak effects at
30-60 minutes, and lasts 2-4 hours [2]. Abusers often
use throughout the day to maintain a consistent high.
At doses of >500mg, users can experience
hallucinations, violent behaviors, and even trancelike states [3]. Poison control recommends ED
evaluation for ingestions of more than 7.5 mg/kg [1].
We report an interesting case of DXM abuse whose
symptoms present as acute psychosis.

Case Report
-

-

-

-

-

-

46 yo male history of depression, schizoaffective,
bipolar disorder, was brought by EMS in restraints for
AMS. He has numerous lacerations on chin and
lower extremities. He is hyperactive, difficult to
redirect, following simple commands, and appears to
be responding to internal stimuli. He denies SI/HI.
Wife reports an empty bottle (237 ml) of Rite Aid
Tussin Cough and Congestion medication containing
20 mg of Dextromethorphan per 10 cc syrup. Noncompliant with psych meds and has had increasing
religious delusions in the past few days.
Initial VS 101.8F, HR 138, RR 20, 145/77, 97% on
RA. WBC 20. Lactate 1.8. BMP 133/4.5/105/10 /9 /
1.55 < 136. AST/ALT 75/54. Neg UDS and UA. CK
759. Etoh, salicylate, acetaminophen negative.
We discussed the case with Poison Control and
provided supportive care for his suspected DXM
overdose including Lorazepam for his agitation. He
met sepsis criteria so covered him empirically with
Ceftriaxone/Doxycycline for suspected aspiration
pneumonia seen on CTAP. AKI improved after fluids.
Transaminitis improved.
During his course, patient’s substance-abuse related
psychosis improved. Patient admitted to abusing
DXM 2-3 times a day for 2 weeks because it “gives
him energy” to read. He recalls cutting himself with
knife to “prove his dedication to God”.
His home medications were restarted including
Aripiprazole, Buproprion, Fluoxetine, Ziprasidone,
Clonazepam. Patient returned to baseline mentation.

Discussion

Dextromethorphan (3-methoxy-N-methylmorphinan)

At very high dosages, DXM can cause agitation, violent
behavior, liver damage, addiction, hallucinations, and
delusions. Effects can be worsened with co-ingestions of
other drugs, especially SSRIs, alcohol or opioids.
Monitor for serotonin syndrome. Labs may show
transaminitis and acute kidney injury. Treatment includes
activated charcoal if ingestion is within 1 hour,
respiratory support, IVFs, and benzodiazepines.

Stages of
intoxication
by dose

Side effects of Dextromethorphan
(DXM) toxicity [3]

1st plateau:
100-200 mg

• Effects similar to ecstasy
• Mild stimulation, uplifting effect
• More energetic, social talkative

2nd plateau:
200-400 mg

• Effects similar to alcohol intoxication
• Decrease in motor and cognitive
function, HTN, slurred speech
• Euphoria and hallucination

3rd plateau:
400-600 mg

• Effects similar to ketamine
• Strong dissociation, intense
hallucinations, loss of motor
coordination, generalized weakness

4th plateau:
500-1500 mg

• Effects similar to PCP
• Effects can last up to 2 weeks
• Trance-like state, out of body
experience, delirium, hallucinations

Conclusion
DXM is an inexpensive OTC medication that is
easily abused for its euphoric properties and can
present to ED as altered mental status. Adverse
drug effects include thermodysregulation, hypoxia,
blurred vision, syncope, respiratory depression.
DXM is known as “the poor man’s PCP” because
intoxication can manifest as extreme agitation,
violent behavior, and florid hallucinations. Do not
delay call to Poison Control and be wary of
fulminant hepatic failure. Supportive care is the
mainstay of therapy.
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